1. Home
  2. CCCC vs CPSS Comparison

CCCC vs CPSS Comparison

Compare CCCC & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • CPSS
  • Stock Information
  • Founded
  • CCCC 2015
  • CPSS 1991
  • Country
  • CCCC United States
  • CPSS United States
  • Employees
  • CCCC N/A
  • CPSS N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • CPSS Finance: Consumer Services
  • Sector
  • CCCC Health Care
  • CPSS Finance
  • Exchange
  • CCCC Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • CCCC 175.1M
  • CPSS 164.5M
  • IPO Year
  • CCCC 2020
  • CPSS 1992
  • Fundamental
  • Price
  • CCCC $2.71
  • CPSS $8.19
  • Analyst Decision
  • CCCC Buy
  • CPSS
  • Analyst Count
  • CCCC 3
  • CPSS 0
  • Target Price
  • CCCC $8.00
  • CPSS N/A
  • AVG Volume (30 Days)
  • CCCC 1.2M
  • CPSS 16.0K
  • Earning Date
  • CCCC 10-30-2025
  • CPSS 10-30-2025
  • Dividend Yield
  • CCCC N/A
  • CPSS N/A
  • EPS Growth
  • CCCC N/A
  • CPSS N/A
  • EPS
  • CCCC N/A
  • CPSS 0.80
  • Revenue
  • CCCC $34,240,000.00
  • CPSS $192,257,000.00
  • Revenue This Year
  • CCCC N/A
  • CPSS $143.76
  • Revenue Next Year
  • CCCC N/A
  • CPSS $14.32
  • P/E Ratio
  • CCCC N/A
  • CPSS $9.75
  • Revenue Growth
  • CCCC 16.55
  • CPSS 2.04
  • 52 Week Low
  • CCCC $1.09
  • CPSS $6.67
  • 52 Week High
  • CCCC $7.22
  • CPSS $12.73
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 60.68
  • CPSS 50.25
  • Support Level
  • CCCC $2.57
  • CPSS $7.15
  • Resistance Level
  • CCCC $2.85
  • CPSS $8.61
  • Average True Range (ATR)
  • CCCC 0.19
  • CPSS 0.34
  • MACD
  • CCCC -0.01
  • CPSS 0.02
  • Stochastic Oscillator
  • CCCC 72.88
  • CPSS 78.51

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: